Intuitive Surgical’s stock fell sharply after it reaffirmed its 2026 da Vinci procedure growth outlook, but warned of slowing U.S. procedure trends and insurance-related headwinds. The management commentary suggests near-term demand and reimbursement pressure despite unchanged guidance, weighing on investor sentiment.
Intuitive Surgical’s stock fell sharply after it reaffirmed its 2026 da Vinci procedure growth outlook, but warned of slowing U.S. procedure trends and insurance-related headwinds. The management commentary suggests near-term demand and reimbursement pressure despite unchanged guidance, weighing on investor sentiment.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment
